Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x100px

Product › Details

Redectane®

	Next higher product group	124I-girentuximab (CA9-SCAN)
	Status	2008-06-06 development p3 existent
	Organisation	IBA (BE) (Ion Beam Applications) (Group)
	Organisation 2	Wilex AG
	Today	Heidelberg Pharma AG (FSE: HPHA)
	Group	Heidelberg Pharma (Group)

Record changed: 2023-07-10

Picture Berlin Partner Top News Robotics Network Berlin-Brandenburg 650x200px

More documents for antibody

[1] Pierre Fabre Laboratories. (3/12/25). "Press Release: Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership". Castres, Cambridge, MA & Basel....
[2] Bambusa Therapeutics, Inc.. (2/14/25). "Press Release: Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases". Boston, MA....
[3] BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg....
[4] Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried....
[5] Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA....
[6] Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets"....
[7] Bambusa Therapeutics, Inc.. (9/9/24). "Press Release: Bambusa Therapeutics Inc. Announces Successful Series Seed Funding to Advance Innovative Bispecific Antibodies for Immunology & Inflammation". Boston, MA....
[8] Epsilogen Ltd.. (9/9/24). "Press Release: Epsilogen Completes £12.5 Million Series B Financing Expansion". London....
[9] Immunic, Inc.. (7/24/24). "Press Release: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec". New York, NY....
[10] Sotio Biotech a.s.. (7/16/24). "Press Release: Sotio Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline". Prague & Beijing....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]